XT
IMMX icon

XTX Topco’s Immix Biopharma IMMX Stock Holding History

XTX Topco’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$738K Buy
81,051
+34,657
+75% +$255K 0.01% 1683
2025
Q4 		$243K Buy
46,394
+11,241
+32% +$46.3K 0.01% 2256
2025
Q3 		$73.5K Buy
+35,153
New +$84.4K ﹤0.01% 2087
2025
Q2 		– Sell
-12,833
Closed -$21.6K – 2737
2025
Q1 		$21.6K Buy
+12,833
New +$24.2K ﹤0.01% 2126
2024
Q3 		– Sell
-17,663
Closed -$35K – 2319
2024
Q2 		$35K Sell
17,663
-34,534
-66% -$79.3K ﹤0.01% 1547
2024
Q1 		$160K Buy
+52,197
New +$202K 0.02% 1243
2022
Q2 		– Sell
-12,992
Closed -$31K – 968
2022
Q1 		$31K Buy
+12,992
New +$48.2K 0.01% 616

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

XTX Topco's IMMX Position: Q1 2026 in Review

XTX Topco increased its Immix Biopharma (IMMX) stake by 75% in Q1 2026, buying an estimated $255K and bringing the position to 81,051 shares worth $738K. The position accounts for 0.01% of the portfolio, ranked #1683.

XTX Topco first reported a position in IMMX in Q1 2022 and has held it in 7 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • XTX Topco held 81,051 shares of Immix Biopharma worth $738K as of Q1 2026.
  • XTX Topco bought 34,657 Immix Biopharma shares in Q1 2026, an estimated $255K.
  • Immix Biopharma made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1683 holding.
  • XTX Topco first reported a position in Immix Biopharma in Q1 2022 and has held it in 7 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.